Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Shares of Waters Corporation (NYSE:WAT) declined 2.2% following the announcement of a $17.5 billion Reverse Morris Trust deal ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Shares of Waters Corp. WAT advanced 2.06% to $287.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...

Waters Corp. is paying $17.5B to merger with the biosciences unit of BD, doubling addressable market to $40B. However, ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

First, Waters Corporation grew earnings per share only with a CAGR of 7.62% in the last ten years and therefore not nearly with a pace high enough to be fairly valued.

Waters Corporation is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

Feb 15 (Reuters) - Lab equipment and software maker Waters Corp (WAT.N), opens new tab said on Wednesday it would buy peer Wyatt Technology for $1.36 billion in cash. The deal, which is expected ...

Shares of Waters Corp. WAT slid 0.21% to $267.48 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.14% to 4,191.98 and Dow ...

Feb 6 (Reuters) - Waters Corp , opens new tab on Tuesday reported fourth-quarter sales ahead of Wall Street estimates, helped by demand for its services used in drug development.